Free Trial

Arcus Biosciences (RCUS) SEC Filings & 10K Form

Arcus Biosciences logo
$9.25 -0.10 (-1.07%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$9.55 +0.30 (+3.23%)
As of 04:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Arcus Biosciences SEC Filings

DateFilerForm TypeView
06/02/2025
7:25 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
4:57 PM
Arcus Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
02/27/2025
6:05 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:06 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:42 PM
Arcus Biosciences (Issuer)
GILEAD SCIENCES, INC. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:43 PM
Arcus Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
Form SCHEDULE 13D/A
02/19/2025
3:05 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
5:44 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:10 PM
Arcus Biosciences (Issuer)
Markus Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2025
8:10 PM
Arcus Biosciences (Issuer)
Markus Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
4:02 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:29 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:31 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:10 PM
Arcus Biosciences (Subject)
Goeltz II Robert C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
8:52 PM
Arcus Biosciences (Subject)
ROSEN TERRY J (Filed by)
Form SC 13D/A
12/17/2024
7:35 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:37 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
3:23 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:25 PM
Arcus Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:11 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
10:31 AM
Arcus Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/17/2024
5:42 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:42 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:12 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:45 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:53 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:RCUS) was last updated on 6/16/2025 by MarketBeat.com Staff
From Our Partners